卵清蛋白八聚体肽
中文名称 | 卵清蛋白八聚体肽 |
---|---|
中文同义词 | 卵清蛋白八聚体肽 |
英文名称 | OVA Peptide (257-264) TFA |
英文同义词 | OVA Peptide (257-264) TFA |
CAS号 | 1262751-08-5 |
分子式 | C47H75F3N10O15 |
分子量 | 1077.17 |
EINECS号 | |
相关类别 | 多肽;目录多肽 |
Mol文件 | 1262751-08-5.mol |
结构式 |
卵清蛋白八聚体肽 性质
溶解度 | DMF:2mg/mL; DMSO:2mg/mL;乙醇:insol; PBS (pH 7.2):不溶 |
---|---|
形态 | 固体 |
序列 | H-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH |
TAP1-I- and C57BL/6 macrophages may process Crl-OVA and full-length OVA in different cellular compartments and that the protein context of the OVA Peptide(257-264) epitope influences the extent of TAP-independent processing for MHC class I presentation. OVA Peptide(257-264) epitope is presented with a differential dependence on the TAP transporter depending on the protein context of the OVA epitope: OVA Peptide(257-264) contained within the MBPCrl-OVA or Crl-OVA bacterial fusion proteins is presented with little dependence on the TAP transporter, while OVA Peptide(257-264) contained within full-length ovalbumin is largely dependent on the TAP transporter, regardless of whether recombinant OVA is expressed in bacteria or the native protein is coupled to polystyrene beads.
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-P1489A | OVA Peptide (257-264) TFA OVA Peptide(257-264) TFA | 1262751-08-5 | 5mg | 3600元 |
2024/04/30 | HY-P1489A | OVA Peptide (257-264) TFA OVA Peptide(257-264) TFA | 1262751-08-5 | 10mg | 4680元 |